v3.26.1
Stock-Based Compensation SSARs (Details) - Stock Appreciation Rights (SARs) [Member]
$ / shares in Units, shares in Thousands, $ in Millions
12 Months Ended
Apr. 30, 2026
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]  
Outstanding, beginning balance | shares 3,878
Granted | shares 897
Exercised | shares 0
Forfeited or expired | shares (722)
Outstanding, ending balance | shares 4,053
Exercisable | shares 2,331
Weighted Average Exercise Price [Roll Forward]  
Weighted average exercise price, beginning | $ / shares $ 55.29
Weighted average exercise price, grants in period | $ / shares 31.10
Weighted average exercise price, exercises in period | $ / shares 0
Weighted average exercise price, forfeitures and expirations in period | $ / shares 41.16
Weighted average exercise price, ending | $ / shares 52.45
Weighted average exercise price, exercisable | $ / shares $ 59.62
Weighted Average Remaining Contractual Term (years) 5 years 3 months 18 days
Weighted Average Remaining Contractual Term (years) 3 years 2 months 12 days
SSARs outstanding, Aggregate Intrinsic Value | $ $ 0
SSARs exercisable, Aggregate Intrinsic Value | $ $ 0